Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Izana Initiates Namilumab Study in Worsening COVID-19

contractpharmaApril 07, 2020

Tag: Izana Bioscience , Namilumab , COVID-19

PharmaSources Customer Service